Column: The political contradictions of progressivism
“The fact is there is no more money. Period,” says Chicago mayor Lori Lightfoot.
She’s talking about the teachers’ strike that has paralyzed her city’s public schools—enrollment 360,000—for the past week. The public employee union is demanding more: more money for salaries (only eight states pay teachers more than Illinois), more support staff (Illinois ranks first in spending on administrators), more teachers per student. Their cause has attracted national attention. Elizabeth Warren joined the picket line.
Which is ironic. Lightfoot is not some stingy Republican. Nor is she a centrist Democrat like her predecessor Rahm Emanuel. She’s as progressive as you can get. But she now finds herself in the same position as many of her political brethren: facing criticism for failing to reconcile the contradictions in the left’s agenda.
Lightfoot has discovered that there is no limit to the appetite of the constituencies generated by government spending. She has learned that the special interests bargaining for higher benefits also desire policies that make such benefits unattainable. I hope she’s taking notes.
Chicago Public Schools has run a deficit for the past seven years. Why? Pensions granted to earlier generations of teachers are expensive. And the cost is growing. A quarter of the school budget is devoted to benefits—money that can’t be spent on classrooms, facilities, and instruction. Expect that number to rise as America goes gray and the bill comes due for the promises we made to ourselves.
The federal government can put Social Security and Medicare on the credit card for as long as demand for U.S. Treasuries is high. States and municipalities don’t have that luxury. There is an upper bound to what even the most progressive mayors and governors can grant the lobbies that mobilize voters for their campaigns. But it’s a glass ceiling. Public sector unions are eager to break it.
Nor does being woke protect you. It’s impossible to appease fully the groups fighting to claim resources and honor. They often won’t take yes for an answer. GM might tout to investors the fact that it is “leading in gender equality.” That didn’t stop the UAW from striking.
Public policy inspired by the ethic of social justice inflames the tension between progressive leaders and the voting public. Andrew Cuomo might sympathize with Mayor Lightfoot. His fealty to environmental groups has backed him into a corner. Banning fracking and canceling pipelines hasn’t just denied New York revenues, jobs, and lower energy bills. It also led energy supplier National Grid to cancel gas hookups in Long Island. Cuomo had to retaliate before the company restored service. Want to be a progressive? Claim credit for resolving a crisis of your own making after threatening to unleash state power on private actors responding to price signals. Cuomo makes it look easy.
Gavin Newsom also has been struggling to reduce the conflict between the imperatives of the new progressivism and the quality of life of everyday people. He has his hands full. Rising numbers of homeless have led to a breakdown of public order in areas of Los Angeles and San Francisco. Land-use regulations have restricted the supply of housing, leading to high prices and shortages, and Newsom’s answer is statewide rent control that will make things worse. California’s budget depends so heavily on revenues from the wealthy that it might not recover from another out-migration like the one the state experienced after a 2012 tax hike.
Pacific Gas & Electric is a case study in the progressive self-own. The state-regulated utility spent years deferring maintenance while it invested in renewable energy and promoted the ideology of diversity, equity, and inclusion. Among the consequences of its neglect were terrible wildfires that devastated communities. The ensuing legal bills drove PG&E into bankruptcy. It says it’s been forced to engage in “de-energization”: purposeful mass blackouts to prevent further damage and legal action. In early October more than two million people were left in the dark. No house, no power, no prospects—welcome to the California Republic.
The contradictions of progressivism generate crises of affordability and governance. But the political class suffers few consequences. Chicago, New York, and California remain Democratic strongholds. What scattered opposition exists is internal to the political machine. On rare occasions parts of the coalition splinter from the whole and are able to defeat radical measures. Think of Bill de Blasio’s stalled plans to cancel entrance exams for New York City’s magnet schools. For the most part, though, the Democrats’ hold on power continues. It’s one monopoly progressives don’t seem to mind.
Are the voters in these communities merely complacent? Are they so content with the patchwork of benefits and status the jerry-rigged welfare state provides that they tolerate dysfunction? Or is the partisan alternative so appalling they won’t even consider it?
Questions worth pondering as progressives prepare to scale up their model nationwide. Who knows? One day, President Warren might be on the other side of that picket line.
WASHINGTON, D.C. – Frontiers of Freedom recently joined 16 other free-market organizations to oppose The Aluminum Pricing Examination (APEX) Act.
The APEX Act would grant the U.S. Commodity Futures Trading Commission expansive authority over the setting of reference prices in the aluminum market, allowing political pressure potentially to distort the market by manipulating price signals.
As part of the effort a coalition letter was released urging Congress to reject the legislation that reads, in part:
By granting the government authority to arbitrarily alter market signals, supporters of the APEX Act—such as certain beer manufacturers with a history of working with politicians to distort the free market—are openly seeking to artificially deflate the price of aluminum. Such an outrageously crony abuse of government is unethical, and history shows that it will only worsen matters by further distorting the market and creating or exacerbating shortages. Domestic producers, faced with extensive government regulations and thinner profit margins, would find it increasingly difficult to survive and further erode domestic supply, a boon for foreign producers.
Republicans and Democrats alike have voiced concerns regarding America’s competitiveness within the aluminum industry. There is wide agreement that the market for American metals must remain a vibrant aspect of the U.S. economy. The APEX Act is dangerous piece of legislation, reflecting both a misunderstanding of industry pricing as well as a misapplication of government authority.
Representatives from the following 17 organizations joined the letter: American Consumer Institute, American Encore, Campaign for Liberty, Center for Freedom and Prosperity, Citizen Outreach, Competitive Enterprise Institute, Consumer Action for a Strong Economy, Frontiers of Freedom, Institute for Liberty, Institute for Policy Innovation, Less Government, Market Institute, National Black Chamber of Commerce, National Tax Limitation Committee, Taxpayers Protection Alliance, Tea Party Nation, and the 60 Plus Association.
Before the passage of ObamaCare, we were told that it would solve all the problems with high costs and accessibility of healthcare. We were repeatedly told that Americans would save thousands of dollars every year. Of course, none of the promised benefits materialized. Now many of the same people who misled us about ObamaCare are now back trying to sell us on other “solutions.”
Speaker Nancy Pelosi — who laughably told us we had to pass ObamaCare to find out what’s in it — is now peddling a new drug plan claiming it will lower costs. However, Pelosi’s plan would supposedly lower costs by imposing up to a 95 percent excise tax on hundreds of prescription medicines. Imposing confiscatory taxes is no way to lower costs, or to encourage innovation. But it is a huge stride towards socialized healthcare which is her real goal. In the end, this plan leaves consumers and patients at the mercy of government bureaucrats. Imagine when you are sick having an experience like at the Department of Motor Vehicles – long lines, lots of waiting, and poor service.
Pelosi’s plan isn’t even constitutional because it imposes a confiscatory retroactive tax on the total sales of a drug, not the profits, but the gross receipts. To escape this ruinous and confiscatory tax, Pelosi’s plan allows drug companies to agree to, and accept, government set prices. This is so abusive that it makes the mob’s protection money schemes look legitimate.
The biggest losers of Pelosi’s plan will be the Americans who will suffer and die because the medicines that could have been developed to cure their condition will not exist or will not have been developed. So as Americans age and need cures for cancer, Alzheimer’s, diabetes, etc, those cures won’t exist and it will be Nancy Pelosi’s fault. These policies have long term consequences. If she were serious about improving things, she would unleash the power of the market and competition. Instead, she empowers government at the expense of Americans.
But there is no shortage of bad ideas on Capitol Hill, masquerading as solutions. For example, Senators Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) have proposed legislation that would change Medicare Part D prescription drug rebates to penalize drugs whose prices rise faster than the rate of inflation. It is strange that the Grassley/Wyden proposal targets Part D because it is one of the few government health care programs to successfully foster price-based productivity increases.
In most parts of the economy, over time, prices go down and quality goes up, due to increases in productivity. The underlying mechanism driving this is competition. One sign of how successful Part D has been in wielding competition is that in its first decade of existence, it cost over 40% less than what the Congressional Budget Office estimated it would. This is an historical achievement.
At the very least, the Grassley/Wyden proposal will increase the cost of participating in the market, both in terms of compliance costs, and in the changed incentives and their inevitable unintended consequences. For example, a company that requires more revenue to economically survive might raise prices slightly on all its products, instead of steeply on just one. How this all plays out is impossible to predict. What can be said for certain is the market’s “logic” would now be less about providing the most value for customers at the lowest price, and now more about the political ramifications of pricing decisions.
The Grassley/Wyden proposal exemplifies the folly of centrally-designed price controls and thus, should be cast in the dustbin of bad socialist ideas.
For example, Senator Bill Cassidy (R-La.) is a medical doctor and has been advocating for market-based approaches to healthcare reform.
There are some good ideas out there. Senators Bill Cassidy (R-La), Steve Daines (R-Mont.), James Lankford (R-Okla.) and Ben Cardin (D-Md.) are sponsoring an amendment to the horribly misguided Grassley/Wyden bill. They suggest creating new tiers of drugs for generics and biosimilars, rather than lumping them in with brandname drugs. This is an idea that makes a lot of sense and it would benefit consumers. But it should be a stand alone bill. The Grassley/Wyden bill is bad enough that such amendments do not actually cure its horrible defects. But the underlying idea of this amendment, as stand alone legislation, would have a lot of merit. The Administration has the authority to do this now under existing statutory authority — it should do so.
The problem with healthcare and medical reforms in Washington is that there is too much blind faith in the ability of big-government to simply wave a wand and somehow magically lower prices. Rather than the promised benefits, what we actually receive are terribly high unintended consequences. We saw this with the ObamaCare fiasco. Policy makers should place their confidence in the marketplace to incentivize innovation and high quality products at competitive prices.
Just last week, Houthi rebels in Yemen, who are closely aligned with Iran, claimed credit for a drone attack on Saudi oil processing facilities.
News changes fast — a surprising development is that now the Houthi’s say Iran is responsible for the attack and that the Iranians have more attacks planned in the near future. The Houthi’s also vowed not to launch any additional attacks themselves.
Something that is not surprising is that missile defense critics in the U.S. are now arguing that the drone attack proves that missile defense doesn’t work. This is, of course, entirely without merit. Meanwhile, Russian President Vladimir Putin is offering Russian missile defense systems to “help” protect against future attacks from its client state of Iran. Let that sink in.
Given Russia’s intimate relationship with Iran, it is entirely possible the attack was coordinated with Russia. It is not as if this would be out of character for Putin. Of course, Putin has never done anything on the international stage simply to be helpful. He is simply trying to help himself and advance his ambitions.
Imagine if he could get U.S. allies to insert and integrate Russian hardware into their U.S.-made defensive systems. Imagine the hacking potential on something like that. Putin would love to learn more about our defensive systems. For that reason, the U.S. earlier this year canceled sales of high-tech American defensive systems to Turkey, a member of NATO, after they integrated Russian equipment in their defensive systems.
But back to the missile defense critics in the U.S. who are unwittingly helping Putin.
Right now very little is actually known about the attack. While preliminary indications are it was a drone attack, we are not even certain precisely what weapons were used. It is profoundly unhelpful to jump to hasty conclusions to support a misguided ideology — particularly when the primary beneficiary of those hasty conclusions will be an adversary like Putin’s Russia.
Beyond not jumping to silly conclusions without any real facts, it is important to realize that an effective missile defense system is layered. Parts of the system protect against ICBMs which actually at some point in their flight are out of the Earth’s atmosphere. Parts of the system protect against intermediate range missiles and other parts protect against shorter range missiles. Each of these missiles has different travel paths and different vulnerabilities. Thus different defenses are needed.
In football, a good defensive coordinator employs a different defense if the opposing team needs only one yard to score than he would if the opposition need twenty-five yards to score. The same concept is true with missile defense.
Having only one layer of missile defense in place to defend against all sorts of attacks leaves the region vulnerable to the other risks. For example, the Patriot defensive missile system is designed to protect against high-flying targets such as jets and ballistic missiles. It wasn’t designed to defend against low flying drones and short range cruise missiles. Patriot’s radars are not intended to scan such low flying means of attack. Nor was Patriot designed to intercept ICBM’s just outside the Earth’s atmosphere. But we know the Patriot system works very well as we’ve seen it in real life combat defend both troops and civilian populations from missile attack.
Criticizing any particular layer of missile defense for not stopping an attack that it was never designed or intended to stop is like criticizing a 350 pound defensive nose tackle for not doing a good job of racing down the sideline to cover a speedy wide receiver. A good defensive football team is made up of different parts, with different skills and capabilities. Together they are a formidable defense. But playing out of position, they are ineffective.
To defend Saudi oil faculties, they would need a layered system — one that has the ability to protect against ballistic missile attack as well as drones and low-flying cruise missiles. Missile defense critics know this, but they don’t care. They simply want to use an unfortunate news event to promote their misguided anti-missile defense ideology in hopes of a short-term political victory.
One of the problems in health care today is that it turns Oscar Wilde’s quip on its head: In the United States, everyone knows the value of health care, but nobody knows the price of anything (because most spending is covered by insurance or by federal programs such as Medicare).
Pricing information is crucial in any system, because when people know what price they’re paying for a good or service, they can make informed decisions. Also, prices tend to come down over time as people demand better service at lower prices.
However, unlike Walmart or Amazon.com, the federal government isn’t especially good at negotiating lower prices. And now, crony health care interests are fighting to eliminate one of Medicare’s few pricing successes.
The issue involves prescription medicines. Since Medicare Part D was put into place to cover prescription drugs, generic and biosimilar medicines have usually been added to the program as soon as the FDA approved them. That’s given seniors access to safe, effective drugs at a much lower cost. In 2018, for example, generic drugs saved consumers almost $300 billion, with $90 billion of that going to Medicare recipients.
Sadly, though, they could have saved much more. In 2016, the Obama administration changed Medicare policy so that many generics would be priced in the same band as name brand drugs. That’s increased prices for seniors by more than $6 billion.
A good chunk of that money flowed to Pharmacy Benefit Managers (PBMs), which negotiate to get the generic meds priced in a higher band, then pocket “rebates” (kickbacks) from the big drug companies that make name brand drugs. Consumers, meanwhile, miss out on potential savings.
Under the Trump administration, the Center for Medicare & Medicaid Services (CMS) is finally taking steps to roll back the price increases. Next year, it wants to stop Medicare Part D plans from moving generic drugs into branded drug tiers. Instead, it plans to create a new tier reserved just for generics and biosimilars.
Many lawmakers support this sensible policy. “I am pleased to find that CMS is considering an ‘alternative’ policy,” Sen. Bill Cassidy of Louisiana wrote to HHS Secretary Alex Azar. “I applaud CMS for considering these cost-effective policies and urge the Agency to make them final for CY2020.”
Cassidy is a doctor and a leader in the fight for a more conservative approach to health care. He also joined fellow Republican Senators Steve Daines and James Lankford and Democrats Sherrod Brown and Robert Menendez in sponsoring an amendment to The Prescription Drug Pricing Reduction Act of 2019 that would have “ensured lower-cost generic drugs are placed on generic tiers and higher-cost brands stay on brand tiers.” They dropped that amendment for internal reasons, because Finance Committee Chairman Charles Grassley told them he’ll make certain the language makes it into the final bill.
Many other lawmakers are also pushing for the reform. “We encourage CMS to move forward with this policy effective CY2020 to lower out-of-pocket costs for millions of Americans, ensuring that they receive the full value of generic and biosimilar competition,” a bipartisan group of House lawmakers wrote to Azar. “Price competition is vital in the Part D program and beneficiaries deserve a choice at the pharmacy counter when possible.”
Seniors can thank these lawmakers, and should keep a sharp eye on Sen. Grassley. He has a chance to move forward in a bipartisan fashion with a plan that would save Medicare recipients money. That ought to be an easy sell in these divided times.
Conservatives are wary about expanding Medicare, of course. But we’re eager to use pricing power to improve the state of American health care. Let’s not allow PBMs to block this important step toward systemic reform.
ATR today released a coalition letter signed by 70 groups and activists in opposition to the Pelosi drug pricing proposal to create a 95 percent tax on pharmaceutical manufacturers.
As noted in the letter, this bill calls for a retroactive tax on sales that is imposed in addition to existing against income taxes:
Under Speaker Pelosi’s plan, pharmaceutical manufacturers would face a retroactive tax of up to 95 percent on the total sales of a drug (not net profits). This means that a manufacturer selling a medicine for $100 will owe $95 in tax for every product sold with no allowance for the costs incurred.
The tax is used to enforce price controls on medicines that will crush innovation and distort the existing supply chain as the signers note:
“The alternative to paying this tax is for the companies to submit to strict government price controls on the medicines they produce. While the Pelosi bill claims this is “negotiation,” the plan is more akin to theft.”
This proposal will create significant harm to American innovation to the detriment of jobs, wages, and patients, as the letter notes:
”[The Pelosi] proposal would crush the pharmaceutical industry, deter innovation, and dramatically reduce the ability of patients to access life-saving medicines.
The full letter is found here and is below:
Dear Members of Congress:
We write in opposition to the prescription drug pricing bill offered by House Speaker Nancy Pelosi that would impose an excise tax of up to a 95 percent on hundreds of prescription medicines.
In addition to this new tax, the bill imposes new government price controls that would decimate innovation and distort supply, leading to the same lack of access to the newest and best drugs for patients in other countries that impose these price controls.
Under Speaker Pelosi’s plan, pharmaceutical manufacturers would face a retroactive tax of up to 95 percent on the total sales of a drug (not net profits). This means that a manufacturer selling a medicine for $100 will owe $95 in tax for every product sold with no allowance for the costs incurred. No deductions would be allowed, and it would be imposed on manufacturers in addition to federal and state income taxes they must pay.
The alternative to paying this tax is for the companies to submit to strict government price controls on the medicines they produce. While the Pelosi bill claims this is “negotiation,” the plan is more akin to theft.
If this tax hike plan were signed into law, it would cripple the ability of manufacturers to operate and develop new medicines.
It is clear that the Pelosi plan does not represent a good faith attempt to lower drug prices. Rather, it is a proposal that would crush the pharmaceutical industry, deter innovation, and dramatically reduce the ability of patients to access life-saving medicines.
We urge you to oppose the Pelosi plan that would impose price controls and a 95 percent medicine tax on the companies that develop and produce these medicines.
President, Americans For Tax Reform
James L. Martin
Founder/Chairman, 60 Plus Association
Saulius “Saul” Anuzis
President, 60 Plus Association
Chair, Alabama Center Right Coalition
President, AMAC Action
President, American Business Defense Council
President, American Commitment
Executive Director, American Conservative Union
President/CEO, The American Consumer Institute Center for Citizen Research
Lisa B. Nelson
CEO, American Legislative Exchange Council
Vice President of Policy, ALEC Action
President, Americans for a Balanced Budget
President, Americans for a Strong Economy
President, Campaign for Liberty
President, Center for a Free Economy
Andrew F. Quinlan
President, Center for Freedom & Prosperity
President, Center for Individual Freedom
Executive Director, Center for Innovation and Free Enterprise
Peter J. Pitts
President, Center for Medicine in the Public Interest
Senior Fellow, Center for Worker Freedom
President, Citizen Outreach
President, Club for Growth
President, The Committee for Justice
Vice President, Competitive Enterprise Institute
Executive Director, Conservatives for Property Rights
President, Consumer Action for a Strong Economy
Fred Cyrus Roeder
Managing Director, Consumer Choice Center
President, Council for Citizens Against Government Waste
Executive Director, Digital Liberty
Co-Chair, Florida Center Right Coalition
President, Frontiers of Freedom
President, Galen Institute
Director of Healthcare Policy, Goldwater Institute
The Honorable Frank Lasee
President, The Heartland Institute
Vice President, Heritage Action for America
Rodolfo E. Milani
Trustee, Hispanic American Center for Economic Research
Founder, Miami Freedom Forum
Mario H. Lopez
President, Hispanic Leadership Fund
President, Independent Women’s Forum
Heather R. Higgins
CEO, Independent Women’s Voice
Resident Scholar, Institute for Policy Innovation
President, Iowans for Tax Relief
Vice President of Policy, The James Madison Institute
The Honorable Paul R LePage
Governor of Maine 2011-2019
President, Less Government
Director, Lone Star Policy Institute
Chair, Maine Center Right Coalition
CEO, The Maine Heritage Policy Center
President, Maine State Chapter – Parents Involved in Education
President, Market Institute
Jameson Taylor, Ph.D.
Vice President for Policy, Mississippi Center for Public Policy
The Honorable Tim Jones
Leader, Missouri Center-Right Coalition
CEO, Montana Policy Institute
President, National Taxpayers Union
The Honorable Bill O’Brien
The Honorable Stephen Stepanek
Co-chairs, New Hampshire Center Right Coalition
The Honorable Beth A. O’Connor
Maine House of Representatives
The Honorable Niraj J. Antani
Ohio State Representative
Executive Director, Ohioans for Tax Reform
Honorable Jeff Kropf
Executive Director, Oregon Capitol Watch Foundation
CEO, Pelican Institute for Public Policy
Executive Director, Property Rights Alliance
President, Rio Grande Foundation
James L. Setterlund
Executive Director, Shareholder Advocacy Forum
President and CEO, Small Business Entrepreneurship Council
David Miller & Brian Shrive
Chairs, Southwest Ohio Center-right Coalition
Executive Director, Taxpayers Protection Alliance
President, Tea Party Nation
Director, Right on Healthcare – Texas Public Policy Foundation
President, Trade Alliance to Promote Prosperity
Executive Director, Wyoming Liberty Group
Something’s happening to wages that neither Democrats nor Republicans care to acknowledge.
By The Atlantic•
Stop me if this sounds familiar: For most American workers, real wages have barely budged in decades. Inequality has skyrocketed. The richest workers are making all the money. Earnings for low-income workers have been pathetic this entire century.
These claims help drive the interpretation of breaking economic news. For example, the Labor Department yesterday reported that the unemployment rate fell to a 50-year low, while wage growth stalled. “The wage numbers here are INSANE,” the MSNBC host Chris Hayes tweeted. “The tightest labor market in decades and decades and ordinary working people are barely seeing gains.”
So, let’s play a game of wish-casting.
It turns out that all three of those things are happening right now.
According to analysis by Nick Bunker, an economist with the jobs site Indeed, wage growth is currently strongest for workers in low-wage industries, such as clothing stores, supermarkets, amusement parks, and casinos. And earnings are growing most slowly in higher-wage industries, such as medical labs, law firms, and broadcasting and telecom companies.
Bunker’s analysis is not an outlier. A Goldman Sachs look at data from the Bureau of Labor Statistics found growth for the bottom half of earners at its highest rate of the cycle. And even among that bottom half, the biggest gains are going to workers earning the least. A New York Times analysis of data from the Federal Reserve Bank of Atlanta found that wage growth among the lowest 25 percent of earners had exceeded the growth in every other quartile.
In fact, according to Bunker’s research, wages for low-income workers may be growing at their highest rate in 20 years.
What’s happening here? Donald Trump hasn’t sprinkled MAGA pixie dust over the U.S. economy. In fact, his trade war has clearly diminished employment growth in industries, that are sensitive to foreign markets, such as manufacturing. Rather, a tight labor market and state-by-state minimum wage hikes have combined to push up wage growth for the poorest workers. The sluggishness of overall wage growth is concealing the fact that the labor market has done wonderful things for wages at the low end.
One reason you haven’t heard this economic narrative may be that it’s inconvenient for members of both political parties to talk about, especially at a time when economic analysis has, like everything else, become a proxy for political orientation. For Democrats, the idea that low-income workers could be benefiting from a 2019 economy feels dangerously close to giving the president credit for something. This isn’t just poor motivated reasoning; it also attributes way too much power to the American president, who exerts very little control over the domestic economy. Meanwhile, corporate-friendly outlets, such as The Wall Street Journal’s editorial pages, have reported on this phenomenon. But they’ve used it as an opportunity to take a shot at “the slow-growth Obama years” rather than a way to argue for the extraordinary benefits of tight labor markets for the poor, much less for the virtues of minimum-wage laws.
Democrats don’t want to talk about low-income wage growth, because it feels too close to saying, “Good things can happen while Trump is president”; and Republicans don’t want to talk about the reason behind it, because it’s dangerously close to saying, “Our singular fixation with corporate-tax rates is foolish and Keynes was right.”
But good things can happen while Trump is president, and Keynes was right. “Tighter labor markets sure are good for workers who work in low-wage industries,” Bunker told me. “This recovery has not been spectacular. But if we let the labor market get stronger for a long time, you will see these results.”
Bill package includes federal rent control, welfare for illegal immigrants and ex-cons
Democratic presidential candidate Elizabeth Warren endorsed a Rep. Alexandria Ocasio-Cortez (D., N.Y.) policy proposal that includes taxpayer-funded welfare benefits for illegal immigrants.
Ocasio-Cortez’s proposal, dubbed “A Just Society,” calls for nationwide rent control and bans the federal government from denying welfare benefits based on an individual’s immigration status and previous criminal convictions. Warren became the first Democratic presidential candidate to endorse the plan, calling it “just the type of bold, comprehensive thinking we’ll need” to make “big, structural change.”
Ocasio-Cortez is considered to be “one of the most important endorsements in America,” and Warren’s immediate support of her latest policy marks another attempt to win the freshman congressman’s nod of approval. Warren’s quick embrace of Ocasio-Cortez’s plan is the latest sign of the social media superstar’s policy impact on the Democratic presidential field.
Neither Ocasio-Cortez nor Warren returned requests for comment.
Ocasio-Cortez’s proposal, consisting of six separate bills, calls for the expansion of welfare. Bills three and four make it illegal for the federal government to deny welfare benefits to ex-convicts and illegal immigrants. The legislation does not address how to pay for the rising cost of welfare, nor does it explain how it would accomplish its goals.
“It’s been really hard for me to find housing. I have the money to move places and stuff, but they deny me for my felony history. It’s not right,” a man with a face tattoo said in the legislative package’s announcement video.
Ocasio-Cortez’s second bill, titled “The Place to Prosper Act,” calls for federal rent control by imposing a 3 percent national cap on annual rent increases. Similar legislation has failed at the local level amid concerns that such policies increased housing prices while limiting supply. A recent study by the American Economic Association found that San Francisco rent control policy “drove up market rents in the long run, ultimately undermining the goals of the law.” The Council of Economic Advisers found that in 11 metropolitan areas with housing regulations, deregulation would reduce homelessness by an average of 31 percent. More than 80 percent of economists surveyed by the University of Chicago in 2012 found rent control to be bad policy.
Ocasio-Cortez’s proposal also includes an official poverty guideline that accounts for “new necessities,” such as internet access, while the fifth bill creates a “worker-friendly score” based on union membership and other factors that would be used to evaluate or award government contracts.
The last bill in Ocasio-Cortez’s proposal establishes health care, housing, and healthy food as government-provided rights.
All major Democratic presidential candidates quickly supported the Green New Deal, including Warren, Sanders, former vice president Joe Biden, and South Bend mayor Pete Buttigieg.
To date, only Warren has endorsed “A Just Society.”
Today, Frontiers of Freedom, along with 12 other organizations dedicated to promoting free markets, limited government, and constitutional principles, sent a letter of caution to President Trump about Notice No. 176, a new, massive regulation proposed by the Alcohol and Tobacco Tax and Trade Bureau (TTB). Among other concerns, the letter warned that Notice No. 176 will add two and a half times the number of regulations governing the distilled spirits industry, seemingly violating both Executive Order 1771 and Executive Order 12866.
The coalition letter reads, in part:
“TTB contends that it released Notice No. 176 to ‘eliminate unnecessary regulatory requirements and provide consumers broader purchasing options.’ Although cloaking it as a deregulatory effort, No. 176 would add two and a half times the number of regulations governing the distilled spirits industry. This comes in stark violation to Executive Order 13771 that you signed on February 3, 2017, which directs all agencies to eliminate two regulations for each new one proposed. Given that Notice No. 176 has also been said to create hundreds of millions in new business costs, it also seemingly violates Executive Order 12866, which states that the OMB’s Office of Information and Regulatory Affairs must review any new significant regulatory action before it is formally proposed.”
The full letter is available here.
Average retirement account would lose $20,000 to tax
A financial transaction tax, though popular with 2020 Democrats, would raise little revenue and substantially shrink the U.S. economy, a recently released report concludes.
A transaction tax takes a percentage from financial trades, such as the sale or purchase of stocks, bonds, or derivatives. The United States levies an extremely small charge on each transaction to fund the Securities and Exchange Commission. A number of Democrats would like to bring a full-fledged financial transaction tax (FTT) back for the first time since 1965.
The idea’s most vocal proponent is presidential contender Sen. Bernie Sanders (I., Vt.) who has introduced a plan to charge a 0.5 percent fee on financial transactions. Sanders has made the tax “on Wall Street” a central revenue source to pay for his exorbitant spending proposals.
Sen. Elizabeth Warren (D., Mass.) introduced her own FTT proposal in 2015, Sen. Kamala Harris (D., Calif.) wants one to pay for expanding Medicare, and Mayor Pete Buttigieg has also said that he is “interested in” implementing an FTT. Congressional Democrats have supported the idea outside of the campaign trail. Sen. Brian Schatz (D., Hawaii) has his own0.1 percent proposed FTT — the bill has more than 200 co-sponsors in the House, including Rep. Alexandria Ocasio-Cortez (D., N.Y.).
These Democrats and others cite several justifications for an FTT. The tax is aimed at “Wall Street,” a preferred target of populist liberals—at least in principle, that means it also falls more heavily on those who hold a lot of wealth in investments. Additionally, such a tax would impose major restrictions on so-called high-frequency trading, which involves computer-run trades at fractions of a penny—profits that could be wiped out by the tax.
“This Wall Street speculation fee, also known as a financial transaction tax, will raise substantial revenue from wealthy investors that can be used to make public colleges and universities tuition free and substantially reduce student debt,” a brief from Sanders’s office reads. “It will also reduce speculation and high-frequency trading that is destabilizing financial markets. During the financial crisis, Wall Street received the largest taxpayer bailout in the history of the world. Now it is Wall Street’s turn to rebuild the disappearing middle class.”
The scope of the tax, however, would extend beyond the confines of Manhattan, according to a report from the Center for Capital Market Competitiveness, an affiliate of the Chamber of Commerce. The report argues that FTTs shrink the economy and hurt every-day Americans, not just Wall Street fat cats.
“Main Street will pay for the tax, not Wall Street,” the report argues. “The real burden [of an FTT] will be on ordinary investors, such as retirees, pension holders, and those saving for college.”
Much like a sales tax, the costs of a financial transaction tax would be passed on to consumers, who would pay more for each trade. Taxing transactions does not just drive up costs for the ultra-wealthy, but the 6 in 10 American households that own some kind of investment. Increased costs would have substantial effects on American savings. Under the Sanders plan, for example, the report estimates that a typical retirement investor will end up losing about $20,000 on average from his IRA.
These direct effects are arguably less significant than the overall effect that an FTT would have on the financial side of the economy. As multiple Democrats have acknowledged, the goal of an FTT would be to crack down on complicated financial instruments, such as high-frequency trades, to reduce what they perceive as dangerous market instability.
These instruments mostly serve vital functions greasing the wheels of the economy, according to the center’s report. An FTT would erase the razor-thin margins on which market makers operate, and severely constrain other forms of arbitrage. They would also reduce the use of vital risk-management tools, like many derivatives and futures contracts.
An FTT, the report argues, would thus serve to substantially slow the economy. Trade volume would fall; consumer good prices would rise; municipal bonds would generate less revenue for infrastructure; the cost of credit would increase, making mortgages more expensive—in turn exacerbating the homelessness crisis, depressing young home-ownership, and reducing family formation.
Obviously, each of these effects may not be massive—the U.S. economy grew substantially even during the 50-year period when we had an FTT. But, the new report argues, the experience of other nations indicates that the costs to the economy would substantially outweigh any benefit.
For example, they cite an economic analysis of a proposed 0.1 percent transaction tax in the EU—the authors found that “such a tax would lower GDP by 1.76 percent while raising revenue of only 0.08% percent of GDP.” Sweden’s 1 percent FTT caused a 5.3 percent drop in the Swedish market—meaning a 0.5 percent FTT, as Sanders proposes, would analogously cut nearly $800 billion from U.S. market capitalization. The evidence runs the other way, too: In the year following the repeal of the U.S. transaction tax, New York Stock Exchange trade volume increased by 33 percent.
All of this is why many countries—including Spain, the Netherlands, Germany, Sweden, Norway, Portugal, Italy, Denmark, Japan, Austria, and France—have eliminated such transaction taxes.
“Bad ideas have a habit of coming around again. The U.S., like many other nations, experimented with an FTT and wisely got rid of it. Yet each generation seems to be tempted by the false promise of a painless revenue stream,” the report said. “It would be wise to pay attention to the wisdom of experience and again avoid this false temptation. After all, those who fail to learn from history are doomed to repeat it.”
Frontiers of Freedom President, George Landrith, made the following statement on Speaker Nancy Pelosi’s so-called Lower Drug Costs Now Act:
“Speaker Nancy Pelosi’s drug pricing plan to impose up to a 95 percent excise tax on hundreds of prescription medicines is the definition of insanity! Even more strange is the counter-intuitive title she’s given it — the Lower Drug Costs Now Act. It is difficult to imagine a more dishonestly named bill. The idea that such actions will reduce prices defies logic. Government obstacles and taxes only raises prices and slow innovation and the development of new medicines and drugs. Imposing confiscatory taxes is no way to encourage innovation or lower prices and it is a huge stride towards socialized healthcare which leaves consumers and patients at the mercy of government bureaucrats. Imagine when you are sick having an experience like at the Department of Motor Vehicles – long lines, lots of waiting, and poor service.
“Pelosi’s plan isn’t even constitutional because it imposes a confiscatory retroactive tax on the total sales of a drug, not the profits, but the gross receipts. To escape this ruinous and confiscatory tax, Pelosi’s plan allows first to agree to government set prices. This is so abusive that it makes the mob’s protection money schemes look legitimate.
“In the long run, the biggest losers will be the Americans who will suffer and die because the medicines that could have been developed to cure their condition will not exist or be developed. So as American age and need cures for cancer, Alhiemers, diabetes, etc, they won’t exist and it will be Nancy Pelosi’s fault. These policies have long term consequences. If she were serious about improving things, she would unleash the power of the market and competition. Instead, she empowers government at the expense of Americans.